Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database
Objective To compare the risk of malignancy between patients with rheumatoid arthritis (RA) initiating their first biological disease-modifying antirheumatic drug (bDMARD) and those continuing conventional synthetic DMARDs (csDMARDs).Methods Nine-year historical Propensity Score (PS) matched cohort...
Main Authors: | Bruno Fautrel, Xavier Mariette, Yann De Rycke, Florence Tubach, Johann castaneda, Raphaele Seror, Sandrine Pinto, Alexandre Lafourcade |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-11-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/8/2/e002139.full |
Similar Items
-
Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort studyResearch in context
by: Maxime Beydon, et al.
Published: (2023-12-01) -
Anthropometric Measures and Risk of Rheumatoid Arthritis in the French E3N Cohort Study
by: Carine Salliot, et al.
Published: (2022-02-01) -
Inappropriate Use of Oral Antithrombotic Combinations in an Outpatient Setting and Associated Risks: A French Nationwide Cohort Study
by: Lorène Zerah, et al.
Published: (2021-05-01) -
Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review
by: Nathalie Gault, et al.
Published: (2017-02-01) -
On the use of propensity scores in case of rare exposure
by: David Hajage, et al.
Published: (2016-03-01)